Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
362 | 3 | SNAKE VENOM//TOXICON//PHOSPHOLIPASE A2 | 35813 |
2423 | 2 | PLATELET ACTIVATING FACTOR//PAF//PAF ANTAGONIST | 4383 |
301 | 1 | PLATELET ACTIVATING FACTOR//PAF//PAF ANTAGONIST | 3730 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PLATELET ACTIVATING FACTOR | authKW | 1303769 | 13% | 31% | 493 |
2 | PAF | authKW | 473894 | 5% | 33% | 171 |
3 | PAF ANTAGONIST | authKW | 417598 | 2% | 60% | 82 |
4 | JOURNAL OF LIPID MEDIATORS | journal | 341027 | 3% | 38% | 105 |
5 | PLATELET ACTIVATING FACTOR PAF | authKW | 206758 | 2% | 39% | 62 |
6 | JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING | journal | 190219 | 2% | 29% | 79 |
7 | PAF RECEPTOR | authKW | 184384 | 1% | 53% | 41 |
8 | PLATELET ACTIVATING FACTOR RECEPTOR | authKW | 131034 | 1% | 48% | 32 |
9 | WEB 2086 | authKW | 129766 | 1% | 59% | 26 |
10 | PLATELET ACTIVATING FACTOR ANTAGONIST | authKW | 128833 | 1% | 51% | 30 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 5526 | 24% | 0% | 896 |
2 | Biochemistry & Molecular Biology | 3892 | 29% | 0% | 1095 |
3 | Immunology | 1802 | 12% | 0% | 450 |
4 | Biophysics | 1512 | 8% | 0% | 307 |
5 | Allergy | 1255 | 3% | 0% | 108 |
6 | Cell Biology | 971 | 10% | 0% | 379 |
7 | Respiratory System | 579 | 4% | 0% | 144 |
8 | Hematology | 531 | 4% | 0% | 165 |
9 | Peripheral Vascular Diseases | 524 | 4% | 0% | 157 |
10 | Physiology | 442 | 5% | 0% | 176 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DEV MED BIOTECHNOL | 35197 | 0% | 83% | 5 |
2 | HB WELLS PEDIAT | 27716 | 0% | 19% | 17 |
3 | 2020 GRAVIER STSUITE B | 16895 | 0% | 100% | 2 |
4 | CATTEDRA NEFROL IMMUNOPATOL | 16895 | 0% | 100% | 2 |
5 | INSERM U200 | 16895 | 0% | 100% | 2 |
6 | MED 1 DIPARTIMENTO BIOCHIM BIOFIS | 16895 | 0% | 100% | 2 |
7 | PHARMACOCHIM MOLEC 2 PL JUSSIEU | 16895 | 0% | 100% | 2 |
8 | TSUKUBA S 13 TOKODAI 5 CHOME | 16895 | 0% | 100% | 2 |
9 | MED MED NEUROSCI | 16891 | 0% | 50% | 4 |
10 | NORA ECCLES HARRISON CARDIOVASC TRAINING INS | 16891 | 0% | 50% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF LIPID MEDIATORS | 341027 | 3% | 38% | 105 |
2 | JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING | 190219 | 2% | 29% | 79 |
3 | AGENTS AND ACTIONS | 15899 | 2% | 2% | 78 |
4 | LIPIDS | 12697 | 3% | 2% | 95 |
5 | PROSTAGLANDINS | 9689 | 1% | 3% | 40 |
6 | PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 6211 | 1% | 3% | 26 |
7 | BRITISH JOURNAL OF PHARMACOLOGY | 5342 | 3% | 1% | 108 |
8 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 5120 | 1% | 3% | 22 |
9 | INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY | 4800 | 1% | 1% | 39 |
10 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 3190 | 1% | 1% | 27 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |